| Literature DB >> 32528104 |
Bradley Feiger1, John Gounley1, Dale Adler2, Jane A Leopold2, Erik W Draeger3, Rafeed Chaudhury4, Justin Ryan4, Girish Pathangey4, Kevin Winarta4, David Frakes4, Franziska Michor5,6,7,8, Amanda Randles9.
Abstract
Comorbidities such as anemia or hypertension and physiological factors related to exertion can influence a patient's hemodynamics and increase the severity of many cardiovascular diseases. Observing and quantifying associations between these factors and hemodynamics can be difficult due to the multitude of co-existing conditions and blood flow parameters in real patient data. Machine learning-driven, physics-based simulations provide a means to understand how potentially correlated conditions may affect a particular patient. Here, we use a combination of machine learning and massively parallel computing to predict the effects of physiological factors on hemodynamics in patients with coarctation of the aorta. We first validated blood flow simulations against in vitro measurements in 3D-printed phantoms representing the patient's vasculature. We then investigated the effects of varying the degree of stenosis, blood flow rate, and viscosity on two diagnostic metrics - pressure gradient across the stenosis (ΔP) and wall shear stress (WSS) - by performing the largest simulation study to date of coarctation of the aorta (over 70 million compute hours). Using machine learning models trained on data from the simulations and validated on two independent datasets, we developed a framework to identify the minimal training set required to build a predictive model on a per-patient basis. We then used this model to accurately predict ΔP (mean absolute error within 1.18 mmHg) and WSS (mean absolute error within 0.99 Pa) for patients with this disease.Entities:
Mesh:
Year: 2020 PMID: 32528104 PMCID: PMC7289812 DOI: 10.1038/s41598-020-66225-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Design of experiments workflow to develop ML models. (a) 65% CoA geometry. (b) The five flow waveforms that were used as features representing a range between rest and exercise. (c) Design of experiments workflow. Step 1) Run 50 simulations in the patient-specific CoA (combination of ten viscosity values and five flow rates). Each simulation can be defined by a viscosity-flow rate pairing. Step 2) In the patient-specific CoA, train and test a neural network to predict ΔP from the simulations. Select 40 simulations for training and ten for the test set. Step 3) If the correlation coefficient R >= 0.98 in the test set, reduce the training set size by one, add that simulation to the test set, and return to Step 2. Otherwise, record the minimum simulation set defined by the viscosity-flow rate pairings in the training set, and return the correlation coefficient for analysis. Step 4) Test the robustness of the ML model by using the minimal simulation set defined by the viscosity-flow rate pairings to run simulations on two different CoA geometries. Also, run nine more simulations in the new geometries to use as a test set. Step 5) In the two new geometries, train and test neural networks to predict ΔP and compute the correlation coefficients in the test set. (d) ML model results for the 50 simulation set in the 65% CoA. (e) ML model results for one of the new 65% CoA geometries using nine simulations in the training set and nine simulations in the test set.
Figure 2Computing ΔP with simulation and ML models. (a) The 65% and artificially narrowed 85% stenosis geometries (Blender version 2.77 - www.blender.org). (b) Sample velocity, WSS, and pressure outputs for the 65% stenosis geometry. (c) Contour plots showing how ΔP relates to viscosity and flow rate in the 65% and 85% stenosis geometries. (d) ML results comparing predicted and simulated ΔP with an associated Blandt-Altman plot.
Figure 3Computing TAWSS with simulation and ML models. (a) Circumferentially averaged TAWSS was computed in a transverse slice distally adjacent to the stenosis. (b) Contour plots showing how TAWSS relates to viscosity and flow rate in the 65% and 85% stenosis geometries. (c) ML results comparing predicted and simulated TAWSS with an associated Blandt-Altman plot. (d) ML results were extended to include WSS at three early time points during the cardiac cycle (0.035, 0.07, and 0.105 seconds) as additional input features with an associated Blandt-Altman plot.
Figure 4Validation of blood flow simulation methods. (a) PIV setup. (b) Results from HARVEY were compared with in vitro flow by plotting time-averaged velocity along a line through the center of the CoA. (c,d) HARVEY comparisons with in vitro flow.